Expanded Radiosurgery Capabilities Utilizing Gamma Knife Icon™.
gamma knife icon
stereotactic radiosurgery
stereotactic radiotherapy
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
19 Mar 2021
19 Mar 2021
Historique:
entrez:
24
3
2021
pubmed:
25
3
2021
medline:
25
3
2021
Statut:
epublish
Résumé
The indications and techniques for the treatment of intracranial lesions continue to evolve with the advent of novel technologies. The Gamma Knife Icon™ (GK Icon™) is the most recent model available from Elekta, providing a frameless solution for stereotactic radiosurgery. At our institution, 382 patients with 3,213 separate intracranial lesions have been treated with frameless stereotactic radiotherapy using the GK Icon. The wide range of diagnoses include brain metastases, meningiomas, arteriovenous malformations, acoustic neuromas, pituitary adenomas, and several other histologies. The ability to perform both frame and frameless treatments on the GK Icon has significantly increased our daily volume by almost 50% on a single machine. Although the frameless approach allows one to take advantage of the precision in radiosurgery, the intricacies regarding treatment with this frameless system are not well established. Our initial experience will help to serve as a guide to those wishing to implement this novel technology in their practice.
Identifiants
pubmed: 33758727
doi: 10.7759/cureus.13998
pmc: PMC7978152
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e13998Informations de copyright
Copyright © 2021, Mendel et al.
Déclaration de conflit d'intérêts
The authors have declared financial relationships, which are detailed in the next section.
Références
N Engl J Med. 1990 Feb 22;322(8):494-500
pubmed: 2405271
PLoS One. 2019 Oct 21;14(10):e0224047
pubmed: 31634366
N Engl J Med. 1998 Nov 12;339(20):1426-33
pubmed: 9811917
Lancet. 2014 Feb 15;383(9917):614-21
pubmed: 24268105
Neurosurgery. 2018 Jul 1;83(1):114-121
pubmed: 28973432
Neuro Oncol. 2019 Feb 14;21(2):242-251
pubmed: 30265328
J Neurosurg. 2014 Dec;121 Suppl:16-25
pubmed: 25434933
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):280-288
pubmed: 27478166
Lancet Oncol. 2014 Apr;15(4):387-95
pubmed: 24621620
J Clin Oncol. 2013 Jan 1;31(1):65-72
pubmed: 23213105
World Neurosurg. 2019 Jun;126:e989-e997
pubmed: 30876993
Lancet Oncol. 2009 Nov;10(11):1037-44
pubmed: 19801201
J Radiosurg SBRT. 2017;4(4):289-301
pubmed: 29296453
Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):291-8
pubmed: 10802351
JAMA. 2016 Jul 26;316(4):401-409
pubmed: 27458945
J Neurosurg. 2018 Sep 7;131(1):227-237
pubmed: 30192195
J Neurosurg. 2018 Jul;129(1):35-47
pubmed: 28984517
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):727-733
pubmed: 29953911
J Neurosurg. 2010 Dec;113 Suppl:73-8
pubmed: 21121789
Prog Neurol Surg. 2019;34:110-124
pubmed: 31096244
J Clin Oncol. 2004 Jul 15;22(14):2865-72
pubmed: 15254054
Acta Chir Scand. 1951 Dec 13;102(4):316-9
pubmed: 14914373
Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):225-30
pubmed: 15337560
Med Phys. 2017 Oct;44(10):5010-5019
pubmed: 28681423
Neurosurgery. 2017 Feb 1;80(2):180-192
pubmed: 28173493
Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1543-8
pubmed: 19135317
J Appl Clin Med Phys. 2019 May;20(5):21-26
pubmed: 31055877
Neurosurgery. 2017 Apr 1;80(4):543-550
pubmed: 28362923
Int J Radiat Oncol Biol Phys. 1995 Feb 15;31(4):983-98
pubmed: 7860415